Advantages of the net benefit regression framework for trial-based economic evaluations of cancer treatments: an example from the Canadian Cancer Trials Group CO.17 trial

Overview of attention for article published in BMC Cancer, June 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 23 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 766 followers.

RT @UCDavis_PHS: Jeffrey Hoch in our @UCDavis_HPM division has developed a better tool to analyze #cancer drug data for cost effectiveness.…

Reply Repost Favourite

Jeffrey Hoch in our @UCDavis_HPM division has developed a better tool to analyze #cancer drug data for cost effectiveness. https://t.co/ymE5csI5IR #netbenefitregression #economicevaluation #costeffectiveness #healtheconomics

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.